As the original SARS-CoV-2 strain continues to mutate, the efficacy for the updated, omicron-targeted vaccines expected to deploy mid-September could depend on each person’s past exposure, The Washington Post reported Aug. 23.
Read the full post on Becker's Hospital Review - Healthcare News
